Role of Peripheral Blood Mononuclear Cells in the Predisposition of Obese Individuals to Inflammation and Infection

Obesity Facts - Tập 6 Số 2 - Trang 146-151 - 2013
Dror Dicker1, Mahmud Abo Salook1, Dana Marcoviciu1, M Djaldetti2, Hanna Bessler2
1Department of Medicine D,
2Laboratory for Hematology and Immunology Research, Rabin Medical Center-Hasharon Hospital, Petah-Tiqva, and the Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel

Tóm tắt

<b><i>Objective</i></b>: To compare the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells (PBMC) from obese but otherwise healthy individuals to that of normal-weight volunteers. <b><i>Methods:</i></b> 25 healthy normal-weight subjects and 41 obese individuals were enrolled. Weight and height were measured twice. PBMC were examined for their capacity to generate pro-inflammatory (TNF-α, IFN-&#947;, IL-1β, IL-6, IL-2) and anti-inflammatory IL-10 and IL-1ra) cytokines. <b><i>Results:</i></b> PBMC from obese individuals, compared to those from subjects with normal weight showed an increased production of the pro-inflammatory cytokines IL-2 (6.7 ± 0.4. vs. 4.9 ± 0.3 ng/ml; p = 0.003), TNF-α (505 ± 45 vs. 277 ± 32 pg/ml; p = 0.001), and IFN-&#947; (93.8 ± 6.0 vs. 73.9 ± 2.7 ng/ml; p = 0.0016). However, PBMC from obese individuals produced a lower amount of the anti-inflammatory cytokine IL-10 (651 ±72 pg/ml) versus those from subjects with normal weight (951 ± 133 pg/ml; p = 0.039). <b><i>Conclusions:</i></b> The findings imply that obese individuals are in a ‘low-grade inflammatory state', presumed to be connected with metabolic and cardiovascular co morbidities. The surplus of pro-inflammatory cytokines produced by circulating mononuclear cells of obese individuals, together with those secreted by adipocytes and non-fat cells in the adipose tissue, may contribute to the predisposition of obese patients to inflammation and infections.

Từ khóa


Tài liệu tham khảo

10.2478/v10039-009-0035-2

10.3810/pgm.2009.11.2074

10.1016/j.giec.2011.02.001

10.1258/ebm.2010.010227

10.1001/archsurg.2011.117

10.1111/j.1469-0691.2010.03362.x

10.1089/jir.2009.0085

10.1111/j.1750-2659.2011.00254.x

10.1038/nature05485

10.1172/JCI57132

10.1172/JCI20514

10.1159/000209979

10.1111/j.1471-0528.2006.01004.x

10.1172/JCI19246

10.1038/sj.ejcn.1601484

10.1016/j.cytogfr.2010.10.005

10.1017/S0029665110001709

10.1016/j.jaci.2005.02.023

10.1159/000277632

10.1159/000289203

10.1016/S0083-6729(06)74018-3

10.1038/sj.ijo.0802594